Researchers have discovered that inflammation could be treated by targeting a molecule called the double-stranded RNA dependent protein kinase (PKR). Persistent and constant inflammation can damage tissue and organs, and lead to diseases such as sepsis, rheumatoid arthritis, and even cancer.